← Back to all trials
Completed
NCT02439775
SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
Conditions: Hypertension, Vascular Diseases, Cardiovascular Diseases
Sex: All
Ages: 20 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 337
Sponsor: Medtronic Vascular
Location: Heart Center Research, LLC Huntsville Alabama
Summary
The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the presence of up to three standard antihypertensive medications.
Eligibility Criteria
Inclusion Criteria:
* Individual has office systolic blood pressure (SBP) ≥ 150 mmHg and \
Source: ClinicalTrials.gov (NCT02439775). StuddyBuddy aggregates publicly available trial information.
